
Publikationen von Christopher Linington
Alle Typen
Zeitschriftenartikel (30)
2012
Zeitschriftenartikel
79 (23), S. 2241 - 2248 (2012)
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 2010
Zeitschriftenartikel
88 (8), S. 753 - 761 (2010)
Axo-glial antigens as targets in multiple sclerosis: Implications for axonal and grey matter injury. Journal of Molecular Medicine
Zeitschriftenartikel
1 (2), S. 47 - 60 (2010)
Identifying targets for autoantibodies in CNS inflammation: Strategies and achievements. Clinical and Experimental Neuroimmunology 2008
Zeitschriftenartikel
588 (1), S. 99 - 105 (2008)
DNA vaccination efficiently induces antibodies to Nogo-A and does not exacerbate experimental autoimmune encephalomyelitis. European Journal of Pharmacology
Zeitschriftenartikel
181 (2), S. 1255 - 1263 (2008)
Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. Journal of Immunology 2007
Zeitschriftenartikel
204 (10), S. 2363 - 2372 (2007)
Neurofascin as a novel target for autoantibody-mediated axonal injury. Journal of Experimental Medicine 2006
Zeitschriftenartikel
36 (3), S. 512 - 515 (2006)
Organ specific autoantigens and the autoreactive T cell repertoire: The case of myelin oligodendrocyte glycoprotein. European Journal of Immunology 2004
Zeitschriftenartikel
63 (12), S. 1284 - 1296 (2004)
Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation. Journal of Neuropathology and Experimental Neurology
Zeitschriftenartikel
172 (1), S. 661 - 668 (2004)
Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. Journal of Immunology
Zeitschriftenartikel
199 (2), S. 185 - 197 (2004)
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. Journal of Experimental Medicine
Zeitschriftenartikel
84 (1), S. 21 - 28 (2004)
Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis. Laboratory Investigation
Zeitschriftenartikel
127, S. 1822 - 1830 (2004)
Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain 2003
Zeitschriftenartikel
171 (1), S. 455 - 461 (2003)
Selective unresponsiveness to conformational B cell epitopes of the myelin oligodendrocyte glycoprotein in H-2(b) mice. Journal of Immunology
Zeitschriftenartikel
100 (16), S. 9446 - 9451 (2003)
Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proceedings of the National Academy of Sciences of the United States of America
Zeitschriftenartikel
126, S. E1 - E1 (2003)
Glatiramer acetate treatment in Devic's neuromyelitis optica - Reply. Brain
Zeitschriftenartikel
139 (1-2), S. 1 - 8 (2003)
Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis. Journal of Neuroimmunology
Zeitschriftenartikel
350 (3), S. 165 - 168 (2003)
Myelin oligodendrocyte glycoprotein is expressed in the peripheral nervous system of rodents and primates. Neuroscience Letters 2002
Zeitschriftenartikel
55 (1), S. 70 - 81 (2002)
Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scandinavian Journal of Immunology
Zeitschriftenartikel
9 (3), S. 243 - 251 (2002)
Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis. European Journal of Neurology
Zeitschriftenartikel
125, S. 1425 - 1427 (2002)
Devic's disease: Bridging the gap between laboratory and clinic. Brain
Zeitschriftenartikel
51 (2), S. 215 - 223 (2002)
Inhibition of autoimmune encephalomyelitis by a tetracycline. Annals of Neurology
Zeitschriftenartikel
12 (3), S. 287 - 299 (2002)
MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury. Brain Pathology 2001
Zeitschriftenartikel
7 (5), S. 285 - 289 (2001)
Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Multiple Sclerosis Journal
Zeitschriftenartikel
113 (2), S. 240 - 248 (2001)
Analysis of interleukin-4 receptor α chain variants in multiple sclerosis. Journal of Neuroimmunology
Zeitschriftenartikel
36 (2), S. 220 - 234 (2001)
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2000
Zeitschriftenartikel
165 (5), S. 2859 - 2865 (2000)
Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. The Journal of Immunology 1999
Zeitschriftenartikel
122, S. 2047 - 2056 (1999)
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study. Brain 1998
Zeitschriftenartikel
153 (3), S. 715 - 724 (1998)
T-cell apoptosis in inflammatory brain lesions - Destruction of T cells does not depend on antigen recognition. American Journal of Pathology
Zeitschriftenartikel
188 (1), S. 169 - 180 (1998)
B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice. Journal of Experimental Medicine
Zeitschriftenartikel
8 (4), S. 681 - 694 (1998)
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathology